PALLIATIVE URINARY DIVERSION BY SUBCUTANEOUS NEPHRO-VESICAL /NEPHRO-CUTANEOUS BYPASS IN END-STAGE MALIGNANT DISEASE

2009 ◽  
Vol 181 (4S) ◽  
pp. 286-286 ◽  
Author(s):  
Joerg Schmidbauer ◽  
Mesut Remzi ◽  
Christoph Klingler ◽  
Christian Kratzik ◽  
Michael Marberger
Keyword(s):  
Urinary Diversion ◽  
Malignant Disease ◽  
Palliative Urinary Diversion ◽  
End Stage

Renal Transplantation in End Stage Renal Disease Patients with Existing Urinary Diversion

1986 ◽  
Vol 135 (4) ◽  
pp. 686-688 ◽  
Author(s):  
Paul MacGregor ◽  
Andrew C. Novick ◽  
Robert Cunningham ◽  
Steven Streem ◽  
Robert Kay ◽  
...  
Keyword(s):  
Renal Transplantation ◽  
Renal Disease ◽  
Urinary Diversion ◽  
End Stage Renal Disease ◽  
Stage Renal Disease ◽  
End Stage

Immunoradiometric method and electrophoretic system compared for quantifying bone alkaline phosphatase in serum

1995 ◽  
Vol 41 (6) ◽  
pp. 853-857 ◽  
Author(s):  
V O Van Hoof ◽  
M Martin ◽  
P Blockx ◽  
A Prove ◽  
A Van Oosterom ◽  
...  
Keyword(s):  
Alkaline Phosphatase ◽  
Malignant Disease ◽  
Screening Method ◽  
Bone Alkaline Phosphatase ◽  
Cross Reactivity ◽  
Osteoblastic Activity ◽  
Alp Activity ◽  
Agarose Electrophoresis ◽  
End Stage ◽  
Rule Out

Abstract Agarose electrophoresis (Isopal, Beckman) and an immunoradiometric assay (IRMA) involving specific monoclonal antibodies (Ostase, Hybritech), two methods for the quantification of serum bone alkaline phosphatase (ALP, EC 3.1.3.1), a marker of osteoblastic activity, were compared in 293 patients: 79 with end-stage renal failure treated with hemodialysis and 214 with malignant disease. Overall correlation between the two methods was good (r = 0.92), except (a) for low values of bone ALP and (b) in some samples with high total liver ALP activity--both due to considerable cross-reactivity of the anti-bone ALP antibodies of the Ostase kit with liver ALP. This interference was not constant and was not evenly distributed across all concentrations of bone ALP. Low bone ALP determined with the IRMA (< or = 5 micrograms/L) was confirmed by electrophoresis (< or = 21 U/L), but bone ALP activity determined by electrophoresis to be low (< or = 21 U/L) was not correlated with the IRMA results. After standardizing our results by computing z-values for bone ALP, delta z (= zOstase - zIsopal) was significantly correlated with liver ALP activity (r = 0.73, P < 0.0001). We conclude that the IRMA for quantifying bone ALP is acceptable as a screening method. However, when high values for bone ALP are found with the Ostase method, confirmation by electrophoresis remains mandatory to rule out cross-reactivity with high amounts of liver ALP. For detecting low bone ALP activities, electrophoresis remains the method of choice.

Palliative Urinary Diversion

1982 ◽  
Vol 62 (6) ◽  
pp. 1025-1034 ◽  
Author(s):  
Enrique P. Perinetti
Keyword(s):  
Urinary Diversion ◽  
Palliative Urinary Diversion

Risk of End Stage Kidney Disease after Radical Cystectomy According to Urinary Diversion Type

2015 ◽  
Vol 193 (4) ◽  
pp. 1283-1287 ◽  
Author(s):  
Joseph R. Zabell ◽  
Oluwakayode Adejoro ◽  
Badrinath R. Konety ◽  
Christopher J. Weight
Keyword(s):  
Kidney Disease ◽  
Radical Cystectomy ◽  
Urinary Diversion ◽  
End Stage Kidney Disease ◽  
End Stage

scholarly journals Pathogenesis of malignant ascites in ovarian cancer patients

2004 ◽  
Vol 12 (2) ◽  
pp. 115-118 ◽  
Author(s):  
Zorica Stanojevic ◽  
Gorana Rancic ◽  
Stojan Radic ◽  
Natasa Potic-Zecevic ◽  
Biljana Djordjevic ◽  
...  
Keyword(s):  
Ovarian Cancer ◽  
Cancer Patients ◽  
Peritoneal Cavity ◽  
Malignant Disease ◽  
Prognostic Significance ◽  
Malignant Ascites ◽  
Malignant Cells ◽  
Stage Disease ◽  
New Treatment ◽  
End Stage

Peritonitis carcinomatosa, indicating the presence of malignant cells in the peritoneal cavity, is a well- known complication of malignant disease. The collection of intraperitoneal fluid in a patient with ovarian cancer is most likely due to intraperitoneal spread of disease. The recognition of small quantities of intraperitoneal fluid may have staging and prognostic significance, while symptomatic large collections may reflect end-stage disease, which permits only palliative therapeutic options. In this paper we dis- cussed the pathogenesis of malignant ascites in ovarian cancer patients and suggested potential new treatment approaches.

Outcome of Palliative Urinary Diversion and Observation for Malignant Extrinsic Ureteral Obstruction

2020 ◽  
Vol 23 (2) ◽  
pp. 254-258 ◽  
Author(s):  
Tomoyuki Tatenuma ◽  
Sogo Tsutsumi ◽  
Masato Yasui ◽  
Go Noguchi ◽  
Susumu Umemoto ◽  
...  
Keyword(s):  
Urinary Diversion ◽  
Ureteral Obstruction ◽  
Palliative Urinary Diversion
Sign in / Sign up

Export Citation Format

Share Document